The UK medical technology sector is valued at approximately £27 billion each year. The UK’s National Health Service (NHS), responsible for 85% of care delivery, is the country’s largest purchaser of healthcare technologies offering significant opportunities for medtech manufacturers. However, top-down structural reorganisation of the NHS, a possible change in government, a post-Brexit regulatory revolution and the drive to Net Zero all present new opportunities and challenges for those seeking to enter the UK market.
Join senior members of Lexington’s healthcare practice and the Association of British Health Tech Industries to discuss these topics, the possible impact on your business, and the implications for ambitions for this exciting and dynamic market.
Learn:
- Introduction to the UK Health System
- UK Medtech market dynamics
- UK political and policy context
- How to get your communications approach right
Alison Woodhouse
Director, Head of Responsible Business
Lexington
Alison Woodhouse is leads Lexington’s Responsible Business practice. She delivers strategic advice on ESG reporting requirements and social value to support business’ with UK procurement, corporate communications and brand partnerships.
Michael Latham
Associate Director
Lexington
Michael Latham is an Associate Director at Lexington. Michael works across the Healthcare practice, with experience and expertise in supporting international medical technology companies, at all stages of development, enter the UK market.
Phil Brown
Director, Regulatory & Compliance
ABHI
Phil Brown joined the ABHI in June 2016 as the Director responsible for regulatory and compliance matters. Phil is a Fellow of TOPRA and lectures at the Sheffield Hallam University on medical device regulatory frameworks.
